Trial intelligence / Profile preview

Phase 2 open-label study of Bisantrene (Xantrene) with fludarabine and clofarabine in relapsed or refractory acute myeloid leukemia

MOH_2021-07-01_010105Phase 2Recruiting

Sponsor

Sheba Medical Center

Start

Jun 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1